Sanofi Detailed Consensus
Last Update: 2020-07-01

Please note: The P&L and the divisions show the restated Q2 2019 and FY 2019 numbers, including the sale of the equity investment in Regeneron.


KPI[EUR m]Q2 2019FY 2019Q2 2020 EFY 2020 EFY 2021 EFY 2022 EFY 2023 EFY 2024 E
Net salesNumber of Estimates121717171717
Net salesHighest8,62837,89540,37543,05945,72148,969
Net salesConsensus (Mean)8,62836,1268,34137,01038,91740,86341,87343,317
Net salesLowest8,09736,50337,71439,26840,01440,340
Other revenuesNumber of Estimates121717171717
Other revenuesHighest3821,6151,6661,7541,8361,960
Other revenuesConsensus (Mean)3521,5053431,5191,5721,6121,6531,698
Other revenuesLowest2611,2991,3341,3741,4121,470
Cost of salesNumber of Estimates121717171717
Cost of salesHighest-2,468-11,582-11,764-11,964-12,031-12,110
Cost of salesConsensus (Mean)-2,767-11,973-2,686-12,167-12,529-12,934-13,208-13,561
Cost of salesLowest-2,814-12,810-13,228-13,879-14,494-15,275
Gross ProfitNumber of Estimates121717171717
Gross ProfitHighest6,23326,85628,89230,93533,06335,601
Gross ProfitConsensus (Mean)6,21325,6585,99826,36227,95929,54130,31831,454
Gross ProfitLowest5,71625,94927,12728,46029,06329,442
- as % of net sales (gross margin)Number of Estimates121717171717
- as % of net sales (gross margin)Highest74.372.673.273.973.874.1
- as % of net sales (gross margin)Consensus (Mean)72.071.071.971.271.872.372.472.6
- as % of net sales (gross margin)Lowest70.670.171.171.371.271.0
R&D expensesNumber of Estimates121717171717
R&D expensesHighest-1,360-5,744-5,832-5,936-5,749-5,485
R&D expensesConsensus (Mean)-1,587-6,018-1,483-5,980-6,063-6,118-6,136-6,210
R&D expensesLowest-1,617-6,095-6,308-6,408-6,504-6,766
SG&A expensesNumber of Estimates121717171717
SG&A expensesHighest-2,233-9,458-9,472-9,301-9,255-9,255
SG&A expensesConsensus (Mean)-2,459-9,883-2,355-9,735-9,831-9,908-9,971-10,089
SG&A expensesLowest-2,524-9,926-10,320-10,425-10,799-11,245
Other current operating income/expenseNumber of Estimates121717171717
Other current operating income/expenseHighest-72-505-805-1,101-1,387-1,640
Other current operating income/expenseConsensus (Mean)-91-382-188-875-1,303-1,738-2,131-2,468
Other current operating income/expenseLowest-263-1,165-1,796-2,337-2,695-3,043
Share of profit/loss of associatesNumber of Estimates121717171717
Share of profit/loss of associatesHighest1345566227659181,010
Share of profit/loss of associatesConsensus (Mean)7999407427476519551
Share of profit/loss of associatesLowest-23-91-81-61-41-21
Net income attributable to non-controlling interestsNumber of Estimates121717171717
Net income attributable to non-controlling interestsHighest-5-29-28-21-22-6
Net income attributable to non-controlling interestsConsensus (Mean)-5-35-8-37-36-35-35-34
Net income attributable to non-controlling interestsLowest-13-50-50-45-45-45
Business operating incomeNumber of Estimates121717171717
Business operating incomeHighest2,41810,41012,14413,31514,72716,693
Business operating incomeConsensus (Mean)2,0789,3492,06410,14211,15312,21812,56313,205
Business operating incomeLowest1,7619,66410,43111,13511,50011,579
- as % of net sales (operating margin)Number of Estimates121717171717
- as % of net sales (operating margin)Highest29.428.230.130.932.234.1
- as % of net sales (operating margin)Consensus (Mean)24.125.924.827.428.729.930.030.4
- as % of net sales (operating margin)Lowest21.625.927.328.428.728.4
Financial income & expenseNumber of Estimates121717171717
Financial income & expenseHighest-69-222-160-110-4626
Financial income & expenseConsensus (Mean)-96-303-84-303-272-242-206-169
Financial income & expenseLowest-110-360-397-378-376-377
- % tax rateNumber of Estimates121717171717
- % tax rateHighest-21.9-21.3-21.4-20.6-20.5-20.3
- % tax rateConsensus (Mean)-22.0-22.0-22.4-22.0-22.0-21.9-21.9-21.9
- % tax rateLowest-25.8-23.1-23.1-22.5-22.1-22.1
Business net incomeNumber of Estimates121717171717
Business net incomeHighest1,8408,0079,35110,35911,52913,166
Business net incomeConsensus (Mean)1,5467,0501,5577,7618,5779,4529,76110,301
Business net incomeLowest1,3247,3597,9418,5118,8209,088
- as % of net sales (net profit margin)Number of Estimates121717171717
- as % of net sales (net profit margin)Highest22.421.923.224.125.226.9
- as % of net sales (net profit margin)Consensus (Mean)17.919.518.721.022.023.123.323.7
- as % of net sales (net profit margin)Lowest16.119.520.721.722.021.8
Number of sharesNumber of Estimates121616161616
Number of sharesHighest1,2561,2551,2561,2561,2571,258
Number of sharesConsensus (Mean)1,2491,2501,2511,2511,2481,2461,2421,238
Number of sharesLowest1,2441,2461,2401,2201,1831,134
Business EPS (in EUR)Number of Estimates121818181717
Business EPS (in EUR)Highest1.476.537.478.279.2110.51
Business EPS (in EUR)Consensus (Mean)1.245.641.246.226.877.567.868.32
Business EPS (in EUR)Lowest1.055.906.396.897.197.25
Dividend Per Share (in EUR)Number of Estimates-1313131212
Dividend Per Share (in EUR)Highest-3.403.744.104.354.88
Dividend Per Share (in EUR)Consensus (Mean)-3.15-3.263.473.723.914.14
Dividend Per Share (in EUR)Lowest-3.143.283.343.413.48
PharmaceuticalsNumber of Estimates121717171717
PharmaceuticalsHighest6,48426,73528,70630,58932,50634,786
PharmaceuticalsConsensus (Mean)6,45925,7006,30526,27427,60628,99129,46030,276
PharmaceuticalsLowest6,09925,83826,80928,03428,33728,366
Consumer HealthcareNumber of Estimates121717171717
Consumer HealthcareHighest1,2324,9005,0695,2695,7296,235
Consumer HealthcareConsensus (Mean)1,1484,6951,1084,7264,8625,0245,2165,445
Consumer HealthcareLowest1,0294,5734,6724,7734,9785,106
VaccinesNumber of Estimates121717171717
VaccinesHighest1,0656,2836,8707,3807,8848,615
VaccinesConsensus (Mean)1,0215,7319276,0066,4456,8447,1947,592
VaccinesLowest6955,6786,0336,2706,4506,585
Dupixent, totalNumber of Estimates121717171717
Dupixent, totalHighest8823,7945,3636,6717,7268,682
Dupixent, totalConsensus (Mean)4962,0748173,4374,6715,7656,7427,581
Dupixent, totalLowest7922,9044,2005,0005,7686,094
MS/Neurology/Other I&INumber of Estimates121515151515
MS/Neurology/Other I&IHighest6552,6412,8563,0182,4701,955
MS/Neurology/Other I&IConsensus (Mean)5922,3455732,4772,6082,7061,8351,343
MS/Neurology/Other I&ILowest5002,3052,3772,4321,464958
AubagioNumber of Estimates121717171717
AubagioHighest5352,1452,2762,3561,6551,090
AubagioConsensus (Mean)4661,8794592,0012,0572,0831,161600
AubagioLowest4011,9011,8931,806784355
LemtradaNumber of Estimates121717171717
LemtradaHighest56230223217211206
LemtradaConsensus (Mean)7428144188160141128117
LemtradaLowest37156112867261
KevzaraNumber of Estimates121717171717
KevzaraHighest83337460667828989
KevzaraConsensus (Mean)5218570282377459520576
KevzaraLowest46214252280316352
Rare DiseasesNumber of Estimates121515151515
Rare DiseasesHighest7893,3963,5613,9174,6985,500
Rare DiseasesConsensus (Mean)7562,9547673,1403,2973,4843,7123,971
Rare DiseasesLowest7223,0563,1743,2393,3643,560
CerezymeNumber of Estimates121616161616
CerezymeHighest188742780794793802
CerezymeConsensus (Mean)187708178717727733735735
CerezymeLowest154682653625599573
CerdelgaNumber of Estimates121616161616
CerdelgaHighest62265316361403437
CerdelgaConsensus (Mean)5020657243273286294304
CerdelgaLowest46222239205143105
MyozymeNumber of Estimates121616161616
MyozymeHighest2531,0031,0901,1611,2201,256
MyozymeConsensus (Mean)2349182459841,0291,0661,1011,136
MyozymeLowest233968956896862828
FabrazymeNumber of Estimates121616161616
FabrazymeHighest2278869319701,0151,077
FabrazymeConsensus (Mean)211813211858896931964996
FabrazymeLowest197842862879894910
AldurazymeNumber of Estimates101313131313
AldurazymeHighest63249275294305318
AldurazymeConsensus (Mean)5422456237244252258263
AldurazymeLowest5322618114511693
Other rare diseasesNumber of Estimates111212121212
Other rare diseasesHighest732953303856501,059
Other rare diseasesConsensus (Mean)208525108125169224281
Other rare diseasesLowest198282858065
OncologyNumber of Estimates111313131313
OncologyHighest1979151,1891,4902,0212,658
OncologyConsensus (Mean)1596381828209351,0581,2781,568
OncologyLowest1527138018489661,084
Libtayo (cemiplimab ex-US sales)Number of Estimates111717171717
Libtayo (cemiplimab ex-US sales)Highest27521493341458596
Libtayo (cemiplimab ex-US sales)Consensus (Mean)01617108172228290346
Libtayo (cemiplimab ex-US sales)Lowest51439495959
Sarclisa (isatuximab)Number of Estimates111616161616
Sarclisa (isatuximab)Highest10114342545750971
Sarclisa (isatuximab)Consensus (Mean)00557188321453593
Sarclisa (isatuximab)Lowest02148108180250
Other oncology (only Fasturtec and Jevtana)Number of Estimates111313131312
Other oncology (only Fasturtec and Jevtana)Highest1747408208909551,070
Other oncology (only Fasturtec and Jevtana)Consensus (Mean)159622160641549441400437
Other oncology (only Fasturtec and Jevtana)Lowest137206252237117234
Rare Blood DisordersNumber of Estimates121515151414
Rare Blood DisordersHighest3081,2731,5511,9712,3132,797
Rare Blood DisordersConsensus (Mean)2911,1522941,2191,3861,6431,9442,209
Rare Blood DisordersLowest2791,1501,2561,3011,6991,817
AlprolixNumber of Estimates121717171717
AlprolixHighest139631618605615660
AlprolixConsensus (Mean)105412114466501523530538
AlprolixLowest101434454454420390
EloctateNumber of Estimates121717171717
EloctateHighest160665667669664639
EloctateConsensus (Mean)171684150612569535508483
EloctateLowest120466463417375381
Cablivi (caplacizumab)Number of Estimates121717171717
Cablivi (caplacizumab)Highest36180420650820950
Cablivi (caplacizumab)Consensus (Mean)155630134236332410472
Cablivi (caplacizumab)Lowest2179111155201222
FitusiranNumber of Estimates21314141414
FitusiranHighest01095280466569
FitusiranConsensus (Mean)-00124106208300
FitusiranLowest000874155
Sutimlimab (BIVV009)Number of Estimates51314141414
Sutimlimab (BIVV009)Highest333117445586739
Sutimlimab (BIVV009)Consensus (Mean)-01867176265352
Sutimlimab (BIVV009)Lowest001856112170
Specialty CareNumber of Estimates111313131313
Specialty CareHighest2,72311,42613,58715,61016,80918,781
Specialty CareConsensus (Mean)2,2949,1632,63611,13112,87514,58415,41816,624
Specialty CareLowest2,54310,82012,52513,87514,10114,696
DiabetesNumber of Estimates121515151515
DiabetesHighest1,2064,8794,7204,7284,7954,937
DiabetesConsensus (Mean)1,2905,1131,1374,7324,4774,3004,1644,010
DiabetesLowest1,0664,6034,3053,9713,7703,562
LantusNumber of Estimates121717171717
LantusHighest6912,7702,5582,4232,3342,257
LantusConsensus (Mean)7583,0126432,6522,3692,1591,9891,821
LantusLowest5842,5652,2231,9581,7211,203
ToujeoNumber of Estimates121717171717
ToujeoHighest2329551,0191,0581,0851,137
ToujeoConsensus (Mean)220883218923947962973983
ToujeoLowest197873877849820803
SoliquaNumber of Estimates121515151515
SoliquaHighest42181224272317356
SoliquaConsensus (Mean)2812236161193219243262
SoliquaLowest31147162174175175
Cardiovascular & Established Products (incl. Generics)Number of Estimates111313131313
Cardiovascular & Established Products (incl. Generics)Highest2,62010,71410,88910,82011,00911,104
Cardiovascular & Established Products (incl. Generics)Consensus (Mean)2,87511,4242,54210,47310,25710,0639,8899,674
Cardiovascular & Established Products (incl. Generics)Lowest2,41310,1949,7949,5018,9208,154
PlavixNumber of Estimates121717171717
PlavixHighest2431,0311,0801,2131,3711,490
PlavixConsensus (Mean)3621,334226930909906909899
PlavixLowest194832742728677626
LovenoxNumber of Estimates121717171717
LovenoxHighest3291,3291,2791,2821,2711,264
LovenoxConsensus (Mean)3471,3593131,2691,1981,1381,0821,031
LovenoxLowest2771,2021,073998948900
Renagel & RenvelaNumber of Estimates111515151515
Renagel & RenvelaHighest68319329352358357
Renagel & RenvelaConsensus (Mean)6631462267249241235229
Renagel & RenvelaLowest56200170150130110
AprovelNumber of Estimates121616161616
AprovelHighest137595628701794786
AprovelConsensus (Mean)173674125536522522524517
AprovelLowest109465445415365320
PraluentNumber of Estimates121717171717
PraluentHighest83338405455497538
PraluentConsensus (Mean)6625845210227261289310
PraluentLowest14130113121127134
MultaqNumber of Estimates121616161616
MultaqHighest88367385392399407
MultaqConsensus (Mean)8234778329307287262243
MultaqLowest6929022912310815
Other RxNumber of Estimates111313131313
Other RxHighest1,7166,9887,1336,8406,7896,731
Other RxConsensus (Mean)1,5246,0641,4806,0185,9165,7685,6325,477
Other RxLowest1,3965,7455,5765,3255,0244,487
GenericsNumber of Estimates121717171717
GenericsHighest2611,0751,0841,1081,1341,159
GenericsConsensus (Mean)2551,0742431,0381,0271,0251,0221,021
GenericsLowest215965888873849821
General MedicinesNumber of Estimates111313131313
General MedicinesHighest3,77715,46915,60915,54815,80416,042
General MedicinesConsensus (Mean)4,16516,5373,67515,20114,73114,36614,06713,709
General MedicinesLowest3,55614,95414,19913,60012,98411,805
Disclaimer

This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.